News and Press Releases

FOR IMMEDIATE RELEASE

September 10, 2007

CONTACTS:
Greta Houlahan
NSF International
Phone: (+1) 734-913-5723
Email: houlahan@nsf.org

Jenny Holliday
David Begg Associates
Phone: +44 (0) 1751 432999
Email: jh@david-begg-associates.com

NSF International Acquires David Begg Associates

Acquisition Provides Expanded Services to the Pharmaceutical and Biotech Industries

(Ann Arbor, MI & Kirkbymoorside, York, UK) - NSF International (NSF), an independent, not-for-profit organization committed to providing public health protection, today announced the acquisition of David Begg Associates (DBA), an organization that provides professional, high-quality training and auditing solutions to the pharmaceutical and healthcare industries.

Together, both NSF and DBA will provide unmatched technical services that will support the testing and training needs of pharmaceutical and biotech companies.  Key stakeholders who will benefit from this acquisition include manufacturers of pharmaceuticals, retailers and consumers. 

“In fulfilling one of our key strategic objectives, we are delighted to become part of NSF International, an organization like ourselves, founded on and developed through sound ethical principles and core values,” said Bob Pietrowski, Managing Partner at DBA. “We are confident that this partnership will bring significant benefits to both parties, and we look forward to the prospect of bringing our unparalleled GMP and regulatory training and auditing expertise to a broader international client base.”

Established in 1986, DBA has an international reputation in the field of pharmaceutical quality management, regulatory compliance and training.   DBA’s leading position in the United Kingdom will give NSF an expanded presence in the European market, while providing additional training services to meet the unique needs of clients worldwide. 

"This is an outstanding opportunity for both organizations to expand our global biotech services," said Kevan P. Lawlor, NSF CEO and President. “Combining DBA’s extensive training and auditing experience with NSF’s unsurpassed testing and certification expertise will position us as a leader in the global pharmaceutical industry.”

This acquisition will also complement other services provided by Global Lifescience Solutions, an NSF International Company that offers a wide array of services to the pharmaceutical, biotech, and dietary supplement industries, including:

  • analytical testing,
  • high-content screening,
  • stability storage and testing, and
  • bioanalytical testing for clinical trials. 

While continuing DBA's mission in providing high-quality, pharmaceutical services, NSF International plans to operate DBA as a standalone business within NSF UK Limited, LLC. 

About David Begg Associates: Established in 1986 to provide expert services to the pharmaceutical and biopharmaceutical industries, David Begg Associates has an outstanding international reputation in the field of pharmaceutical quality management, regulatory compliance and, in particular, for its high-quality training courses (http://www.david-begg-associates.com).

About NSF International: NSF International, an independent, not-for-profit organization, helps protect you by certifying products and writing standards for food, water and consumer goods (www.nsf.org). Founded in 1944, NSF is committed to protecting public health and safety worldwide.  NSF is a World Health Organization Collaborating Centre for Food and Water Safety and Indoor Environment. Additional services include safety audits for the food and water industries, management systems registrations delivered through NSF International Strategic Registrations, organic certification provided by Quality Assurance International and education through the NSF Center for Public Health Education.

Bookmark and Share